글로벌 연구동향
방사선종양학
- 2019년 05월호
[Radiother Oncol.] Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma.연세의대 / 변화경, 성진실*
- 출처
- Radiother Oncol.
- 등재일
- 2019 Apr
- 저널이슈번호
- 133:1-8. doi: 10.1016/j.radonc.2018.12.025. Epub 2019 Jan 11.
- 내용
Abstract
PURPOSE:
To evaluate the effects of dose escalation by intensity-modulated radiotherapy (IMRT) in liver-directed concurrent chemoradiotherapy for locally advanced Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma (BCLC-C HCC).MATERIALS AND METHODS:
During 2005-2016, 637 patients with BCLC-C HCC received RT with concurrent hepatic arterial 5-fluorouracil. Patients were divided into two groups according to the biologically effective doses for a tumor (α/β = 10 Gy): <72 Gy (536 patients) and ≥72 Gy (101 patients). In each group, 128/536 (24%) and 94/101 patients (93%) used IMRT, respectively.RESULTS:
The median follow-up for patients alive at the time of analysis was 36 months (range, 6-159 months). For ≥72 Gy and <72 Gy groups, the median overall survival (OS) was 21 and 13 months, respectively (P = .002). The 1-year local failure-free survival (LFFS) were significantly higher in high-dose group (95% vs. 79%; P < .001). After propensity score matching, high-dose group still had significantly better 1-year OS (62% vs. 51%; P = .03) and 1-year LFFS (95% vs. 78%; P = .008). In the multivariate model, RT dose was an independent predictor of LFFS and OS. The surgical conversion rate was significantly higher in high-dose group (20% vs. 12%, P = .03), with substantially increased median OS among patients who underwent surgery (104 months vs. 11 months; P < .001). There were no significant differences in gastrointestinal bleeding or radiation-induced liver disease.CONCLUSIONS:
In liver-directed concurrent chemoradiotherapy, radiation dose escalation by IMRT increased LFFS and OS for locally advanced BCLC-C HCC. It also increased the conversion rate to curative resection, which was attributable to increased OS.
Author informationByun HK1, Kim HJ2, Im YR1, Kim DY3, Han KH3, Seong J4.
1
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
2
Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, South Korea.
3
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
4
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: jsseong@yuhs.ac.
- 키워드
- Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Intensity modulated radiotherapy; Radiation dose–response relationship
- 덧글달기
- 이전글 [Radiother Oncol.] Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.
- 다음글 [Radiat Oncol.] Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation.